Valuation: Kenvue Inc.

Market Cap 36.84B 31.97B 29.94B 27.38B 51.7B 3,509B 52.37B 350B 137B 1,753B 138B 135B 5,836B P/E 2026 *
20.5x
P/E 2027 * 17.7x
Enterprise Value 43.91B 38.1B 35.68B 32.64B 61.61B 4,182B 62.42B 417B 164B 2,090B 165B 161B 6,955B EV / Sales 2026 *
2.81x
EV / Sales 2027 * 2.72x
Free-Float
98.9%
Yield 2026 *
4.41%
Yield 2027 * 4.49%
1 day-0.18%
1 week-0.65%
Current month-0.65%
1 month-3.36%
3 months+7.87%
6 months+5.14%
Current year+10.81%
1 week 18.68
Extreme 18.685
19.7
1 month 18.58
Extreme 18.58
20.05
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
21.96
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Fiscal year

Executive/Senior Manager

32,838 0.0017%
5/1/26 Fiscal year

Group President LATAM

55,637 0.0029%
3/30/26 Free

Director

1,331 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%-0.65%-12.16%-18.80% 36.83B
-1.21%+0.44%-5.45%-7.52% 342B
-0.83%-1.54%-8.24%+1.48% 136B
-0.32%+1.42%+9.31%+20.41% 74.14B
+0.79%-0.56%-17.34%-17.67% 51.29B
+2.51%+3.98%-4.36%-48.73% 30.93B
-0.88%+0.59%-19.32%-31.48% 20.59B
+1.58%+7.98%+6.72%+31.49% 20.54B
+0.14%+1.80%+15.32%+9.81% 20.09B
-2.53%-2.06%-12.69%+3.19% 11.57B
Average -0.07%+0.75%-4.82%-5.78% 74.4B
Weighted average by Cap. -0.56%+0.00%-5.20%-5.01%

Financials

2026 *2027 *
Net sales 15.62B 13.55B 12.69B 11.61B 21.92B 1,488B 22.2B 148B 58.27B 743B 58.64B 57.37B 2,474B 16.01B 13.89B 13.01B 11.9B 22.46B 1,525B 22.76B 152B 59.72B 762B 60.1B 58.79B 2,536B
Net income 1.8B 1.57B 1.47B 1.34B 2.53B 172B 2.57B 17.15B 6.73B 85.88B 6.77B 6.63B 286B 2.08B 1.81B 1.69B 1.55B 2.92B 198B 2.96B 19.81B 7.77B 99.17B 7.82B 7.65B 330B
Net Debt 7.07B 6.13B 5.74B 5.25B 9.91B 673B 10.04B 67.17B 26.36B 336B 26.53B 25.95B 1,119B 6.75B 5.86B 5.49B 5.02B 9.48B 643B 9.6B 64.2B 25.19B 321B 25.35B 24.8B 1,070B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-08-07 US$19.14 -0.23% 3,243,001
26-08-06 US$19.18 -2.49% 25,328,494
26-08-05 US$19.67 +0.61% 32,808,027
26-08-04 US$19.55 +2.84% 23,595,514
26-08-03 US$19.01 -1.20% 35,167,488
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.18USD
Average target price
19.83USD
Spread / Average Target
+3.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock